Helge Espelid

Olaparib monotherapy as primary treatment in unselected triple negative breast cancer

Hans Petter Eikesdal, Synnøve Yndestad, Ahmed El‐Zawahry et al. · Annals of Oncology · 2020 · 226 citations · Full text

Medicine, Oncology, Pharmacology +16

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study

Hildegunn Høberg‐Vetti, Cathrine Bjorvatn, Bent Fiane et al. · European Journal of Human Genetics · 2015 · 76 citations · Full text

Life Sciences, Genetics, Oncology +15

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development

Oleksii Nikolaienko, Hans Petter Eikesdal, Elisabet Ognedal et al. · Genome Medicine · 2023 · 33 citations · Full text

Life Sciences, Genetics, Oncology +14

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

Synnøve Yndestad, Christina Engebrethsen, Andrea Herencia-Ropero et al. · JCO Precision Oncology · 2023 · 26 citations · Full text

Medicine, Genetics, Oncology +16